1418 DACLATASVIR COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN FOR 12 OR 16 WEEKS IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION: COMMAND GT2/3 STUDY

✍ Scribed by Dore, G.J.; Lawitz, E.; H'ezode, C.; Shafran, S.; Ramji, A.; Tatum, H.; Taliani, G.; Tran, A.; Brunetto, M.; Zaltron, S.; Strasser, S.; Weis, N.; Ghesquiere, W.; Lee, S.; Larrey, D.; Pol, S.; Harley, H.; George, J.; Fung, S.; de L'edinghen, V.; Hagens, P.; Cohen, D.; Cooney, E.; Noviello, S.; Hughes, E.

• Book ID: 123585058
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 78 KB
• Volume: 58
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(13)61417-8